🇺🇸 FDA
Patent

US 9114068

Treating patients with intravenous ibuprofen

granted A61KA61K31/19A61K31/192

Quick answer

US patent 9114068 (Treating patients with intravenous ibuprofen) held by Cumberland Pharmaceuticals Inc. expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Cumberland Pharmaceuticals Inc.
Grant date
Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/19, A61K31/192, A61K31/198, A61K9/0019